🟢 Strong Evidence
A comprehensive physiological analysis published in Physiological Reviews (2024) demonstrates that maximal oxygen uptake (VO₂max)—the body’s capacity to utilize oxygen during exercise—outperforms conventional cardiovascular risk markers as a predictor of long-term health outcomes and mortality risk. The evidence shows that individuals maintaining higher cardiorespiratory fitness across the lifespan experience substantially lower all-cause mortality rates, with fitness levels in the “exceptional” range conferring approximately five times lower mortality risk compared to the lowest fitness groups.
Key takeaways
- VO₂max is a stronger independent predictor of mortality and longevity than blood pressure or cholesterol levels
- Individuals in the highest fitness percentiles have approximately five times lower all-cause mortality risk compared to the lowest fitness group
- VO₂max can be improved by 10–20% through regular aerobic training, even in older adults, and declines naturally by approximately 7–10% per decade without intervention
- The aerobic frailty threshold (below 17.5 mL/kg/min) marks a critical boundary where functional capacity and survival outcomes become severely compromised
Study at a Glance
| Source | Physiological Reviews |
| Study type | Comprehensive physiological review and analysis |
| Focus | VO₂max as predictor of health outcomes across populations |
| Key finding | Cardiorespiratory fitness outperforms traditional risk markers for mortality prediction |
| Population | Multiple age groups and fitness levels across lifespan |
VO₂max Levels and Mortality Risk Across Fitness Categories
All-cause mortality risk reduction relative to sedentary baseline (mL/kg/min)
Source: Physiological Reviews, 2024 | Georgian Medical Journal News
VO₂max: A Superior Marker of Systemic Health
According to the Physiological Reviews analysis, VO₂max—measured in millilitres of oxygen per kilogramme of body weight per minute (mL/kg/min)—integrates function across the entire oxygen delivery chain, making it a more comprehensive health marker than isolated measurements like blood pressure or low-density lipoprotein cholesterol. The research demonstrates that elite endurance athletes achieve values between 70–90 mL/kg/min, whilst sedentary adults typically average below 45 mL/kg/min.
The physiological basis for VO₂max’s predictive power lies in its dependence on multiple organ systems working in concert. Efficient lungs and respiratory muscles must draw oxygen from air, red blood cells must transport it through the bloodstream, the heart must pump oxygenated blood under sufficient pressure, blood vessels must distribute oxygen to tissues, and skeletal muscles must extract and metabolize oxygen efficiently to generate adenosine triphosphate (ATP) for contraction. This integrated systems assessment explains why VO₂max captures health status more comprehensively than single risk factors.
Fitness Decline, Age, and Mortality Risk Stratification
The Physiological Reviews data reveal that whilst VO₂max declines naturally with advancing age at a rate of approximately 7–10% per decade in sedentary individuals, individuals who maintain high fitness levels throughout the lifespan experience dramatically reduced mortality rates across all age groups. Individuals in the “exceptional” fitness range—above the 90th percentile—demonstrate approximately five times lower all-cause mortality risk compared to those in the lowest fitness quintile, according to the analysis.
Equally significant, individuals in the “above average” fitness category (45–52 mL/kg/min) experience over 40% reduction in mortality risk compared to the aerobic frailty threshold group, whilst even those in the “average” fitness range achieve approximately 20% mortality risk reduction. This dose-response relationship suggests that progressive improvements in cardiorespiratory fitness yield measurable survival benefits at every threshold, making it a highly modifiable health determinant. Regular aerobic exercise can increase VO₂max by 10–20%, rendering this fitness component more responsive to intervention than many fixed genetic risk factors.
The Aerobic Frailty Threshold and Clinical Implications
The research identifies VO₂max below 17.5 mL/kg/min as the “aerobic frailty threshold,” a boundary below which functional capacity and health resilience become severely compromised. Values approaching 10.5 mL/kg/min mark a mortality threshold where activities of daily living and independent survival become threatened. These thresholds carry particular clinical significance for ageing populations and individuals with chronic disease, where cardiorespiratory function directly determines capacity for self-care and quality of life.
The implications for clinical practice and patient management are substantial. Unlike blood pressure or cholesterol—which require pharmaceutical intervention for many patients—VO₂max can be improved through non-pharmacological means. Aerobic exercise training consistently raises VO₂max by 10–20% even in older adults and those with pre-existing cardiovascular disease, suggesting that fitness-based interventions may offer comparable or superior mortality reduction compared to many conventional medications.
Individuals in the exceptional fitness range have approximately five times lower risk of all-cause mortality compared to those in the lowest fitness group, with even above-average fitness conferring over 40% mortality reduction.
— Physiological Reviews Analysis (2024)
What this means
Frequently asked questions
How is VO₂max measured in clinical practice?
VO₂max is measured through cardiopulmonary exercise testing (CPET), where patients exercise to maximum effort on a treadmill or stationary bicycle whilst oxygen consumption and carbon dioxide production are continuously measured via indirect calorimetry. The test typically takes 8–12 minutes and yields a direct measurement of maximal oxygen uptake. Field estimates (such as the six-minute walk test or timed running distance) offer less precise approximations but may be used for screening or monitoring in resource-limited settings.
Can cardiorespiratory fitness improvements reduce medication dependence in hypertension or diabetes?
Research demonstrates that sustained aerobic exercise can lower blood pressure by 5–10 mmHg and improve glucose metabolism sufficiently to reduce medication requirements in some patients with hypertension and type 2 diabetes. However, fitness improvements should complement—not replace—prescribed medications without explicit clinical guidance. Patients should discuss exercise-based therapy with their clinician to determine whether medication adjustment is appropriate as fitness improves.
At what age is it too late to improve cardiorespiratory fitness?
Studies demonstrate that VO₂max improvements are achievable across the entire lifespan, including in adults over 80 years. A single year of aerobic exercise training can increase VO₂max by 10–20% even in older individuals previously sedentary for decades. However, improvements may be somewhat smaller in very advanced age, and exercise programmes should be adapted for individual capacity and comorbidities to ensure safety and adherence.
The growing body of physiological evidence positioning VO₂max as a superior longevity and health predictor suggests that clinical medicine and public health policy should allocate greater resources to cardiorespiratory fitness assessment and aerobic exercise prescription. As populations age and non-communicable disease burden rises, interventions that strengthen oxygen delivery systems across the lifespan offer a scalable, cost-effective, and evidence-supported strategy for extending healthy life expectancy and preventing frailty and functional decline.
Source: Physiological Reviews: Cardiorespiratory Fitness as a Predictor of Health and Mortality (2024)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
